These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33022072)

  • 1. Evaluation and applicability of Alere iCup DX 14 for rapid postmortem urine drug screening at autopsy.
    Towler S; Concheiro M; Pearring S; Rodda LN
    J Forensic Sci; 2021 Jan; 66(1):375-382. PubMed ID: 33022072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the on-site immunoassay drug-screening device Triage-TOX in routine forensic autopsy.
    Tominaga M; Michiue T; Maeda H
    Leg Med (Tokyo); 2015 Nov; 17(6):499-502. PubMed ID: 26593997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are point-of-care urine drug testing devices suitable for antenatal drug screening? A study verifying the Alere® Drug Screen Test Cup for the detection of six classes of drug in a pregnant population.
    Dale RC; Ford LT; Street C
    Ann Clin Biochem; 2021 May; 58(3):166-173. PubMed ID: 33435699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls.
    Avcioglu G; Yilmaz G; Yalcin Sahiner S; Kozaci LD; Bal C; Yilmaz FM
    Clin Biochem; 2021 Jul; 93():112-118. PubMed ID: 33882283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of drug screening in forensic autopsy: retrospective investigation of routine toxicological findings.
    Tominaga M; Michiue T; Inamori-Kawamoto O; Hishmat AM; Oritani S; Takama M; Ishikawa T; Maeda H
    Leg Med (Tokyo); 2015 May; 17(3):172-6. PubMed ID: 25637163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine toxicology screening by liquid chromatography time-of-flight mass spectrometry in a quaternary hospital setting.
    Pope JD; Black MJ; Drummer OH; Schneider HG
    Clin Biochem; 2021 Sep; 95():66-72. PubMed ID: 33989561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine Multi-drug Screening with GC-MS or LC-MS-MS Using SALLE-hybrid PPT/SPE.
    Lee J; Park J; Go A; Moon H; Kim S; Jung S; Jeong W; Chung H
    J Anal Toxicol; 2018 Nov; 42(9):617-624. PubMed ID: 29762685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A threshold LC-MS/MS method for 92 analytes in oral fluid collected with the Quantisal® device.
    Desharnais B; Lajoie MJ; Laquerre J; Mireault P; Skinner CD
    Forensic Sci Int; 2020 Dec; 317():110506. PubMed ID: 33035929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in post-mortem whole blood.
    Pelletti G; Rossi F; Garagnani M; Barone R; Roffi R; Fais P; Pelotti S
    Forensic Sci Int; 2020 Jul; 312():110291. PubMed ID: 32353744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum on Hitachi 912.
    Kirschbaum KM; Musshoff F; Schmithausen R; Stockhausen S; Madea B
    Forensic Sci Int; 2011 Oct; 212(1-3):252-5. PubMed ID: 21775079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous humor as an alternative matrix for comprehensive drug screening in postmortem toxicology by liquid chromatography-time-of-flight mass spectrometry.
    Pelander A; Ristimaa J; Ojanperä I
    J Anal Toxicol; 2010; 34(6):312-8. PubMed ID: 20663283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Intraosseous Fluid as an Alternative Biological Specimen in Postmortem Toxicology.
    Rodda LN; Volk JA; Moffat E; Williams CM; Lynch KL; Wu AHB
    J Anal Toxicol; 2018 Apr; 42(3):163-169. PubMed ID: 29272445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Method for the identification and quantification of sixty drugs and their metabolites in postmortem whole blood using liquid chromatography tandem mass spectrometry.
    Al-Asmari AI
    Forensic Sci Int; 2020 Apr; 309():110193. PubMed ID: 32142991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of three point-of-care urinalysis test devices for drugs of abuse and therapeutic drugs applied in the emergency department.
    Attema-de Jonge ME; Peeters SY; Franssen EJ
    J Emerg Med; 2012 Jun; 42(6):682-91. PubMed ID: 21911284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-MS-MS vs ELISA: Validation of a Comprehensive Urine Toxicology Screen by LC-MS-MS and a Comparison of 100 Forensic Specimens.
    Kahl KW; Seither JZ; Reidy LJ
    J Anal Toxicol; 2019 Oct; 43(9):734-745. PubMed ID: 31424082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine.
    Krasowski MD; Pizon AF; Siam MG; Giannoutsos S; Iyer M; Ekins S
    BMC Emerg Med; 2009 Apr; 9():5. PubMed ID: 19400959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmortem drug screening by non-targeted and targeted ultra-performance liquid chromatography-mass spectrometry technology.
    Rosano TG; Wood M; Swift TA
    J Anal Toxicol; 2011 Sep; 35(7):411-23. PubMed ID: 21871149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Triage DOA®, Status DS10, and DRIVEN-FLOW® M8-Z on-site drug screening kits for postmortem urine.
    Tanaka T; Yoshida K; Kasai K; Yoshizumi S; Sato H
    Leg Med (Tokyo); 2022 Feb; 54():101993. PubMed ID: 34808562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of 108 illicit drugs and metabolites in bile matrix by LC-MS/MS for the toxicological testing of sudden death cases.
    Franzin M; Ruoso R; Peruch M; Stocco G; D'Errico S; Addobbati R
    Arch Toxicol; 2024 Jan; 98(1):135-149. PubMed ID: 38051366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.